Project Grant K23DA061933

Award Date 4/15/25
Completion Date 3/31/30
Dollars Obligated $194K
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
Massachusetts, USA
Similar Awards
This National Institute on Drug Abuse (NIDA) Project Grant award for $508,034 under the Drug Use and Addiction Research Programs (CFDA 93.279) supports the adaptation and pilot testing of a digital screening and brief intervention program for perinatal substance use delivered through home visiting services. The study aims to optimize a tailored electronic screening and brief intervention (SBI-HV) program for integrating into routine home visiting programs, and to systematically assess...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $1,464,467 to Baystate Medical Center, Inc. to test the effectiveness of the "Mothering from the Inside Out" (MIO) parenting intervention for mothers with substance use disorders. The key products or services to be delivered under this 5-year award include: (1) conducting a randomized effectiveness trial to evaluate MIO plus...
The National Institute on Drug Abuse (NIDA) awarded a $2,467,574 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to Boston Medical Center Corporation to develop and evaluate an evidence-based universal overdose prevention intervention for youth. The project aims to increase awareness of fentanyl and other emerging drug risks, knowledge of strategies to reduce overdose, and recognition and response to overdose among youth ages 13-26 receiving annual physical...
This federal Project Grant award, in the amount of $1,499,606.00, was provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The grant will support a population-level analysis of 1.7 million racially and ethnically diverse maternal-infant dyads insured by Medicaid to characterize the health and developmental trajectories of children born to individuals with opioid use disorder (OUD). Key objectives include: Examining...
The National Institute on Drug Abuse (NIDA) awarded Magee-Womens Research Institute and Foundation a $3,092,159 Project Grant under the Drug Abuse and Addiction Research Programs (CFDA 93.279) to conduct a multimodal analysis of gestational health and placental injury in opioid-affected pregnancies. The goal is to investigate the direct impact of illicit and prescription opioids on placental development, differentiation, and function, focusing on the critical syncytiotrophoblast and...
The National Institutes of Health (NIH) awarded Boston Medical Center Corporation a $2,573,346 Project Grant under the Drug Abuse and Addiction Research Programs (CFDA 93.279). The 3-year grant, which commenced on September 1, 2023, will fund a prospective cohort study comparing 100 opioid-exposed pregnancies to 50 non-exposed controls. The study aims to: Compare serial microRNA (miRNA) signatures in opioid-exposed and control pregnancies using maternal plasma and placental tissue samples....
The National Institute on Drug Abuse (NIDA) awarded The Washington University a 3-year, $2,337,729 Project Grant under the Drug Abuse and Addiction Research Programs (CFDA 93.279) to study the impact of prenatal opioid exposure on placental and fetal brain development. The project, titled "The Opioid in Pregnancy: Imaging of Oxygenation, Inflammation, and Development in Brain & Placenta" (OPIOID BPP), aims to define the longitudinal effects of prenatal opioid exposure on...
This Project Grant from the National Institute on Drug Abuse, part of the Department of Health and Human Services, provides $738,086 to Brown University under the Drug Abuse and Addiction Research Programs (CFDA 93.279) to evaluate a technology-assisted parenting intervention for adolescents in residential substance use treatment. Specifically, the funding supports a randomized controlled trial to test the effectiveness of Parent SMART, a mobile app and telehealth coaching program that...
This is a Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) federal grant program. The $193,550 award will fund the development of a peer breastfeeding support intervention for mothers with opioid use disorder (OUD). The key objectives of this project are to: 1) engage mothers with OUD to identify breastfeeding facilitators and understand the potential influence of breastfeeding on OUD recovery; 2) facilitate...
This $994,004 project grant was awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The overarching goal of the grant is to engage adolescents, young adults, parents, providers, pharmacists, and people who use drugs to generate knowledge to guide future interventions and co-create adaptations to reduce youth overdose risk. Specifically, the project will: 1) Explore perceptions of overdose risk, the drug supply, and safety...

The National Institute on Drug Abuse (NIDA) awarded a $193,752 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to Boston Medical Center Corporation (BMC) to test the effectiveness of a video-coaching intervention called THRIVE to promote responsive parenting for mothers with opioid use disorder (OUD) and their preschool children. The goals are to identify implementation facilitators and barriers in the pediatric primary care setting, engage staff and mothers in implementation planning, and conduct a pilot trial to test both implementation and effectiveness outcomes. The project aims to make empirically supported parenting interventions more accessible and acceptable for dyads affected by OUD, especially during the critical preschool period when behavior problems often first manifest. The award will fund activities from April 2025 through March 2030.

Generated 4/8/25, 3:14 AM